Agnes Bernet

Title: Agnes Bernet: Innovator in Anti-Cancer Research

Introduction

Agnes Bernet is a notable inventor based in Genas, France. She has made significant contributions to the field of cancer research, particularly in the development of methods for screening anti-cancer compounds. Her innovative work focuses on the interaction of these compounds with the netrin-1 receptor, which plays a crucial role in cancer progression.

Latest Patents

Agnes Bernet holds a patent for her invention titled "Screening for anti-cancer compounds using netrin-1 activity." This patent describes an in vitro method for screening anti-cancer compounds based on their ability to interact with the netrin-1 receptor and inhibit the dimerization of its intracellular domain in tumor cells. The invention also provides a method for predicting the presence of metastatic or aggressive cancer by measuring the expression level of netrin-1. Additionally, it includes kits and compounds for treating cancers, such as metastatic breast cancer, associated with the overexpression of netrin-1 in tumor cells. She has 1 patent to her name.

Career Highlights

Throughout her career, Agnes has worked with esteemed organizations, including the Centre National de la Recherche Scientifique and the Centre Léon Bérard. Her research has significantly advanced the understanding of cancer biology and therapeutic strategies.

Collaborations

Agnes Bernet has collaborated with notable colleagues such as Patrick Mehlen and Julien Fitamant. Their joint efforts have contributed to the advancement of cancer research and the development of innovative treatment methods.

Conclusion

Agnes Bernet is a pioneering inventor whose work in anti-cancer research has the potential to impact the lives of many. Her innovative methods for screening anti-cancer compounds highlight the importance of continued research in the fight against cancer.